OAB-044: Efficacy and Safety of Cilta-Cel in Patients with Progressive Multiple Myeloma after Exposure to BCMA-targeting Antibody-Drug Conjugate Treatment
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2022)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined